4Y4 Stock Overview
Designs, manufactures, and markets ultraviolet light water treatment and surface disinfectant devices for individuals and professionals in France, rest of Europe, Asia, the Middle East, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
BIO-UV Group S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.90 |
| 52 Week High | €3.15 |
| 52 Week Low | €1.45 |
| Beta | 0.42 |
| 1 Month Change | 19.20% |
| 3 Month Change | -1.86% |
| 1 Year Change | -20.17% |
| 3 Year Change | -63.32% |
| 5 Year Change | n/a |
| Change since IPO | -68.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4Y4 | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | 13.0% | -3.2% | -2.6% |
| 1Y | -20.2% | 7.4% | 6.9% |
Return vs Industry: 4Y4 underperformed the German Machinery industry which returned 7.4% over the past year.
Return vs Market: 4Y4 underperformed the German Market which returned 6.9% over the past year.
Price Volatility
| 4Y4 volatility | |
|---|---|
| 4Y4 Average Weekly Movement | 6.7% |
| Machinery Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4Y4 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 4Y4's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 155 | Laurent-Emmanuel Migeon | www.bio-uv.com |
BIO-UV Group S.A. designs, manufactures, and markets ultraviolet light water treatment and surface disinfectant devices for individuals and professionals in France, rest of Europe, Asia, the Middle East, the United States, and internationally. It offers O’Clear UV treatment, a disinfection system for water; DELTA-UV, a disinfection system for pools and spas; BIO-UV INOX for a chlorine-free water treatment; BIO-UV COMBIPOOL, an automatic injection and pH regulation for pools; BIO-UV REGUL pH for pools to maintain pH levels; and BIO-UV TEMPO for pools to control the duration of daily remanent injections according to water temperature. The company also provides MP Touch Screen and MPL Super Deluxe for the dechloramination of commercial and semi-commercial pools; DW for the production of drinking water; RW for the tertiary treatment of municipal wastewater disinfection; RW, IAM, and IBP for the treatment of industrial process water; BIO-SEA for the treatment of ballast water on ships; BIO-SUN for water disinfection in remote areas; and BIO-UV Kit UV Home3 3F for domestic water treatment.
BIO-UV Group S.A. Fundamentals Summary
| 4Y4 fundamental statistics | |
|---|---|
| Market cap | €19.81m |
| Earnings (TTM) | -€724.38k |
| Revenue (TTM) | €39.93m |
0.5x
P/S Ratio-27.3x
P/E RatioIs 4Y4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4Y4 income statement (TTM) | |
|---|---|
| Revenue | €39.93m |
| Cost of Revenue | €15.28m |
| Gross Profit | €24.66m |
| Other Expenses | €25.38m |
| Earnings | -€724.38k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.071 |
| Gross Margin | 61.75% |
| Net Profit Margin | -1.81% |
| Debt/Equity Ratio | 67.7% |
How did 4Y4 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yield54%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 17:27 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BIO-UV Group S.A. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephanie Lefebvre | Gilbert Dupont |
| Martin Tessier | Stifel, Equities Research |
| Martin Tessier | Stifel Europe |